BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 27629874)

  • 1. Factors associated with cancer worries in individuals participating in annual pancreatic cancer surveillance.
    Konings IC; Harinck F; Kuenen MA; Sidharta GN; Kieffer JM; Aalfs CM; Poley JW; Smets EM; Wagner A; van Rens A; Vleggaar FP; Ausems MG; Fockens P; van Hooft JE; Bruno MJ; Bleiker EM;
    Fam Cancer; 2017 Jan; 16(1):143-151. PubMed ID: 27629874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repeated participation in pancreatic cancer surveillance by high-risk individuals imposes low psychological burden.
    Konings IC; Sidharta GN; Harinck F; Aalfs CM; Poley JW; Kieffer JM; Kuenen MA; Smets EM; Wagner A; van Hooft JE; van Rens A; Fockens P; Bruno MJ; Bleiker EM
    Psychooncology; 2016 Aug; 25(8):971-8. PubMed ID: 26632416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of Neoplastic Progression in Individuals at High Risk for Pancreatic Cancer Undergoing Long-term Surveillance.
    Canto MI; Almario JA; Schulick RD; Yeo CJ; Klein A; Blackford A; Shin EJ; Sanyal A; Yenokyan G; Lennon AM; Kamel IR; Fishman EK; Wolfgang C; Weiss M; Hruban RH; Goggins M
    Gastroenterology; 2018 Sep; 155(3):740-751.e2. PubMed ID: 29803839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient-reported burden of intensified surveillance and surgery in high-risk individuals under pancreatic cancer surveillance.
    Overbeek KA; Cahen DL; Kamps A; Konings ICAW; Harinck F; Kuenen MA; Koerkamp BG; Besselink MG; van Eijck CH; Wagner A; Ausems MGE; van der Vlugt M; Fockens P; Vleggaar FP; Poley JW; van Hooft JE; Bleiker EMA; Bruno MJ;
    Fam Cancer; 2020 Jul; 19(3):247-258. PubMed ID: 32193697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Feasibility of a pancreatic cancer surveillance program from a psychological point of view.
    Harinck F; Nagtegaal T; Kluijt I; Aalfs C; Smets E; Poley JW; Wagner A; van Hooft J; Fockens P; Bruno M; Bleiker EM
    Genet Med; 2011 Dec; 13(12):1015-24. PubMed ID: 21857231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benefit of Surveillance for Pancreatic Cancer in High-Risk Individuals: Outcome of Long-Term Prospective Follow-Up Studies From Three European Expert Centers.
    Vasen H; Ibrahim I; Ponce CG; Slater EP; Matthäi E; Carrato A; Earl J; Robbers K; van Mil AM; Potjer T; Bonsing BA; de Vos Tot Nederveen Cappel WH; Bergman W; Wasser M; Morreau H; Klöppel G; Schicker C; Steinkamp M; Figiel J; Esposito I; Mocci E; Vazquez-Sequeiros E; Sanjuanbenito A; Muñoz-Beltran M; Montans J; Langer P; Fendrich V; Bartsch DK
    J Clin Oncol; 2016 Jun; 34(17):2010-9. PubMed ID: 27114589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Value of EUS in early detection of pancreatic ductal adenocarcinomas in patients with intraductal papillary mucinous neoplasms.
    Kamata K; Kitano M; Kudo M; Sakamoto H; Kadosaka K; Miyata T; Imai H; Maekawa K; Chikugo T; Kumano M; Hyodo T; Murakami T; Chiba Y; Takeyama Y
    Endoscopy; 2014 Jan; 46(1):22-9. PubMed ID: 24218310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dilemmas in the management of screen-detected lesions in patients at high risk for pancreatic cancer.
    Ibrahim IS; Bonsing BA; Swijnenburg RJ; Welling L; Veenendaal RA; Wasser MN; Morreau H; Inderson A; Vasen HF
    Fam Cancer; 2017 Jan; 16(1):111-115. PubMed ID: 27406244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term yield of pancreatic cancer surveillance in high-risk individuals.
    Overbeek KA; Levink IJM; Koopmann BDM; Harinck F; Konings ICAW; Ausems MGEM; Wagner A; Fockens P; van Eijck CH; Groot Koerkamp B; Busch ORC; Besselink MG; Bastiaansen BAJ; van Driel LMJW; Erler NS; Vleggaar FP; Poley JW; Cahen DL; van Hooft JE; Bruno MJ;
    Gut; 2022 Jun; 71(6):1152-1160. PubMed ID: 33820756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Key endoscopic ultrasound features of pancreatic ductal adenocarcinoma smaller than 20 mm.
    Aso A; Ihara E; Osoegawa T; Nakamura K; Itaba S; Igarashi H; Ito T; Aishima S; Oda Y; Tanaka M; Takayanagi R
    Scand J Gastroenterol; 2014 Mar; 49(3):332-8. PubMed ID: 24417737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PanGen-Fam: Spanish registry of hereditary pancreatic cancer.
    Mocci E; Guillen-Ponce C; Earl J; Marquez M; Solera J; Salazar-López MT; Calcedo-Arnáiz C; Vázquez-Sequeiros E; Montans J; Muñoz-Beltrán M; Vicente-Bártulos A; González-Gordaliza C; Sanjuanbenito A; Guerrero C; Mendía E; Lisa E; Lobo E; Martínez JC; Real FX; Malats N; Carrato A
    Eur J Cancer; 2015 Sep; 51(14):1911-7. PubMed ID: 26212471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case of small pancreatic cancer with intra-pancreatic metastasis diagnosed by endoscopic ultrasound.
    Ogawa M; Kawaguchi Y; Uchida T; Ito H; Mine T
    Tokai J Exp Clin Med; 2011 Sep; 36(3):75-8. PubMed ID: 21932188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pancreatic Cancer Surveillance in Carriers of a Germline
    Klatte DCF; Boekestijn B; Wasser MNJM; Feshtali Shahbazi S; Ibrahim IS; Mieog JSD; Luelmo SAC; Morreau H; Potjer TP; Inderson A; Boonstra JJ; Dekker FW; Vasen HFA; van Hooft JE; Bonsing BA; van Leerdam ME
    J Clin Oncol; 2022 Oct; 40(28):3267-3277. PubMed ID: 35658523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variation in precursor lesions of pancreatic cancer among high-risk groups.
    Potjer TP; Schot I; Langer P; Heverhagen JT; Wasser MN; Slater EP; Klöppel G; Morreau HM; Bonsing BA; de Vos Tot Nederveen Cappel WH; Bargello M; Gress TM; Vasen HF; Bartsch DK; ;
    Clin Cancer Res; 2013 Jan; 19(2):442-9. PubMed ID: 23172884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Late-Stage Pancreatic Cancer Detected During High-Risk Individual Surveillance: A Systematic Review and Meta-Analysis.
    Chhoda A; Vodusek Z; Wattamwar K; Mukherjee E; Gunderson C; Grimshaw A; Sharma A; Ahuja N; Kastrinos F; Farrell JJ
    Gastroenterology; 2022 Mar; 162(3):786-798. PubMed ID: 34813861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pancreatic Cancer Surveillance and Novel Strategies for Screening.
    Dudley B; Brand RE
    Gastrointest Endosc Clin N Am; 2022 Jan; 32(1):13-25. PubMed ID: 34798981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of endoscopic retrograde pancreatography for early detection of pancreatic ductal adenocarcinoma concomitant with intraductal papillary mucinous neoplasm of the pancreas.
    Ohtsuka T; Ideno N; Aso T; Nagayoshi Y; Kono H; Mori Y; Takahata S; Oda Y; Aishima S; Igarashi H; Ito T; Ishigami K; Nakamura M; Mizumoto K; Tanaka M
    J Hepatobiliary Pancreat Sci; 2013 Mar; 20(3):356-61. PubMed ID: 22878836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short-term Results of a Magnetic Resonance Imaging-Based Swedish Screening Program for Individuals at Risk for Pancreatic Cancer.
    Del Chiaro M; Verbeke CS; Kartalis N; Pozzi Mucelli R; Gustafsson P; Hansson J; Haas SL; Segersvärd R; Andren-Sandberg Å; Löhr JM
    JAMA Surg; 2015 Jun; 150(6):512-8. PubMed ID: 25853369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does the interval from imaging to operation affect the rate of unanticipated metastasis encountered during operation for pancreatic adenocarcinoma?
    Glant JA; Waters JA; House MG; Zyromski NJ; Nakeeb A; Pitt HA; Lillemoe KD; Schmidt CM
    Surgery; 2011 Oct; 150(4):607-16. PubMed ID: 22000171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Familial pancreatic cancer in Italy. Risk assessment, screening programs and clinical approach: a position paper from the Italian Registry.
    Del Chiaro M; Zerbi A; Capurso G; Zamboni G; Maisonneuve P; Presciuttini S; Arcidiacono PG; Calculli L; Falconi M;
    Dig Liver Dis; 2010 Sep; 42(9):597-605. PubMed ID: 20627831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.